Position in LUCD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,341,748
+$1,969,781 QoQ
Shares Held
2,188,550
+576.6% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#9
of 114 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LUCD Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026FIRST MANHATTAN CO. LLC. holds $119,421,457 across 9 Medical Devices names. LUCD ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
1,697,334 | $72,442,215 | |
| 2 | SYK |
Stryker Corp
|
88,504 | $27,864,599 | |
| 3 | ABT |
Abbott Laboratories
|
107,475 | $9,752,281 | |
| 4 | MDT |
Medtronic plc
|
52,309 | $4,092,133 | |
| 5 | LUCD |
Lucid Diagnostics Inc.
This page
|
2,188,550 | $2,341,748 | |
| 6 | PAVM |
PAVmed Inc.
|
332,911 | $1,977,491 | |
| 7 | STE |
STERIS plc
|
2,373 | $499,682 | |
| 8 | CERS |
Cerus Corp
|
82,000 | $239,440 |
All Filings in LUCD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,341,748 | 2,188,550 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $371,967 | 323,450 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $352,560 | 323,450 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $326,684 | 323,450 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $371,967 | 323,450 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,774 | 12,600 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,319 | 12,600 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,269 | 12,600 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,332 | 12,600 | Shares | Sole | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||